Corpus Intelligence Bayesian Calibration — AKRON GENERAL MEDICAL CENTER 2026-04-26 04:07 UTC
Bayesian Calibration — AKRON GENERAL MEDICAL CENTER
CCN 360027 | Data quality: D (0% complete) | 0/9 metrics
🛡️ Public data only — no PHI permitted on this instance.
D
Data Quality Grade
0%
Completeness
0/9
Metrics Provided
9
Missing (Imputed)
0
Suspicious Values

Missing Data is Informative

Over 30% of metrics are missing. In healthcare PE diligence, sellers who don't provide denial/AR data often have worse-than-average performance. Bayesian estimates below are shrunk toward peer priors — treat as conservative baselines, not forecasts.

Missing: Denial Rate, Clean Claim Rate, Net Collection Rate, First Pass Resolution, Appeals Overturn Rate, Days In Ar

Bayesian-Calibrated KPI Estimates

Each metric combines peer-group prior (from 401-bed hospital benchmarks) with observed data. Shrinkage shows the weight given to prior vs observed: 0% = all data, 100% = all prior. Green bar = data weight, amber = prior weight.

MetricPriorObservedPosterior90% CIShrinkageData vs PriorQuality
Denial Rate6.5%6.5%[0.0%, 13.8%]100%
Prior Only
Clean Claim Rate94.5%94.5%[88.6%, 100.0%]100%
Prior Only
Net Collection Rate97.5%97.5%[93.2%, 100.0%]100%
Prior Only
First Pass Resolution82.0%82.0%[69.6%, 94.4%]100%
Prior Only
Appeals Overturn Rate52.0%52.0%[34.1%, 69.9%]100%
Prior Only
Days In Ar38.038.0[28.6, 47.4]100%
Prior Only
Cost To Collect1.8%1.8%[1.4%, 2.2%]100%
Prior Only
Dnfb Days4.04.0[3.0, 5.0]100%
Prior Only
Charge Lag Days2.02.0[1.5, 2.5]100%
Prior Only

Methodology: Hierarchical Bayesian Partial Pooling

Rate metrics (denial rate, collection rate, clean claim rate) use Beta-Binomial conjugate updating. Continuous metrics (AR days, cost to collect) use Gamma/Normal approximation. Priors are stratified by hospital type (large/medium/small/rural). With zero observations, the posterior equals the prior. As n increases, the posterior converges to the observed value and the credible interval narrows. This prevents unstable estimates from thin data while letting real evidence dominate.